These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 37998293

  • 1. Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.
    Genrinho I, Ferreira PL, Santiago T, Carones A, Mazeda C, Barcelos A, Beirão T, Costa F, Santos I, Couto M, Rato M, Terroso G, Monteiro P.
    Int J Environ Res Public Health; 2023 Nov 14; 20(22):. PubMed ID: 37998293
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).
    Rocha LF, Marangoni RG, Sampaio-Barros PD, Levy-Neto M, Yoshinari NH, Bonfa E, Steen V, Kowalski SC.
    Clin Rheumatol; 2014 May 14; 33(5):699-706. PubMed ID: 23975361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
    Ferreira PL, Genrinho I, Santiago T, Carones A, Mazeda C, Barcelos A, Beirão T, Costa F, Santos I, Couto M, Rato M, Terroso G, Monteiro P.
    Int J Environ Res Public Health; 2023 Jan 14; 20(2):. PubMed ID: 36674306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
    Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, Marjanovic Z, Heneggar C, Papo T, Crickx B, Sereni D, Cabane J, Farge D.
    Clin Rheumatol; 2005 Feb 14; 24(1):3-10. PubMed ID: 15674652
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
    Becker MO, Dobrota R, Garaiman A, Debelak R, Fligelstone K, Tyrrell Kennedy A, Roennow A, Allanore Y, Carreira PE, Czirják L, Denton CP, Hesselstrand R, Sandqvist G, Kowal-Bielecka O, Bruni C, Matucci-Cerinic M, Mihai C, Gheorghiu AM, Mueller-Ladner U, Sexton J, Kvien TK, Heiberg T, Distler O.
    Ann Rheum Dis; 2022 Apr 14; 81(4):507-515. PubMed ID: 34824049
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic Sclerosis Quality of Life Questionnaire (SScQoL): translation into Turkish and assessing its psychometric properties.
    Sarac DC, Bayraktar D, Tore NG, Kurut Aysin I, Otman E, Inanc I, Demirbas S, Coskun B, Erol K, Ustun O, Akatay EA, Oskay D, Gucenmez S, Ozmen M, Akar S.
    Clin Rheumatol; 2023 Aug 14; 42(8):2135-2143. PubMed ID: 37178266
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
    Meijs J, Pors D, Vliet Vlieland TP, Huizinga TW, Schouffoer AA.
    Clin Exp Rheumatol; 2014 Aug 14; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis.
    Gualtierotti R, Ingegnoli F, Scalone L, Cortesi P, Bruschi E, Gerosa M, Meroni PL.
    Swiss Med Wkly; 2016 Aug 14; 146():w14394. PubMed ID: 28102877
    [Abstract] [Full Text] [Related]

  • 19. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, Scleroderma Clinical Trials Consortium.
    Arthritis Rheum; 2002 Sep 14; 46(9):2410-20. PubMed ID: 12355489
    [Abstract] [Full Text] [Related]

  • 20. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis.
    Lee TH, Lee JS, Park S, Lee KA, Kim HS.
    Korean J Intern Med; 2021 Nov 14; 36(6):1504-1514. PubMed ID: 33561335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.